Protein Kinase C Modifications of VE-cadherin, P120, and Beta-catenin Contribute to Endothelial Barrier Dysregulation Induced by Thrombin
Overview
Molecular Biology
Physiology
Pulmonary Medicine
Affiliations
The adherens junction is a multiprotein complex consisting of the transmembrane vascular endothelial cadherin (VEC) and cytoplasmic catenins (p120, beta-catenin, plakoglobin, alpha-catenin) responsible for the maintenance of endothelial barrier function. Junctional disassembly and modifications in cadherin/catenin complex lead to increased paracellular permeability of the endothelial barrier. However, the mechanisms of junctional disassembly remain unclear. In this study, we used the proinflammatory mediator thrombin to compromise the barrier function and test the hypothesis that phosphorylation-induced alterations of VEC, beta-catenin, and p120 regulate junction disassembly and mediate the increased endothelial permeability response. The study showed that thrombin induced dephosphorylation of VEC, which is coupled to disassembly of cell-cell contacts, but VEC remained in aggregates at the plasma membrane. The cytoplasmic catenins dissociated from the VEC cytoplasmic domain in thin membrane projections formed in interendothelial gaps. We also showed that thrombin induced dephosphorylation of beta-catenin and phosphorylation of p120. Thrombin-induced interendothelial gap formation and increased endothelial permeability were blocked by protein kinase C inhibition using chelerythrine and Gö-6976 but not by LY-379196. Chelerythrine also prevented thrombin-induced phosphorylation changes of the cadherin/catenin complex. Thus the present study links posttranslational modifications of VEC, beta-catenin, and p120 to the mechanism of thrombin-induced increase in endothelial permeability.
Bacalbasa N, Petrea S, Gaspar B, Pop L, Varlas V, Hasegan A In Vivo. 2024; 38(6):2945-2954.
PMID: 39477394 PMC: 11535961. DOI: 10.21873/invivo.13777.
The impact of platelets on the metastatic potential of tumour cells.
Raskov H, Orhan A, Agerbaek M, Gogenur I Heliyon. 2024; 10(14):e34361.
PMID: 39114075 PMC: 11305202. DOI: 10.1016/j.heliyon.2024.e34361.
Jing H, Wu X, Xiang M, Wang C, Novakovic V, Shi J Cancers (Basel). 2023; 15(7).
PMID: 37046617 PMC: 10093313. DOI: 10.3390/cancers15071957.
McEvoy E, Sneh T, Moeendarbary E, Javanmardi Y, Efimova N, Yang C Nat Commun. 2022; 13(1):7089.
PMID: 36402771 PMC: 9675837. DOI: 10.1038/s41467-022-34701-y.
Parenteral Nutrition and Cardiotoxicity.
Van Nispen J, Voigt M, Song E, Armstrong A, Fedorova M, Murali V Cardiovasc Toxicol. 2021; 21(4):265-271.
PMID: 33554318 DOI: 10.1007/s12012-021-09638-1.